StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)

Close on Nov 18, 2026Market cap $104.20MP/E –Yield –

NovaBridge Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for NovaBridge Biosciences

NovaBridge Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NovaBridge Biosciences figures

See a number that looks wrong?